DeepCure Raises $24M to Propel AI-Driven Drug Discovery Forward
DeepCure, a spin-out from MIT, aims to revolutionize small molecule therapeutics discovery using artificial intelligence (AI) and automated chemistry, addressing challenging targets in the pharmaceutical industry.
